Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.




FirmAnalyst Phone
BofA Securities
Juan Avendano
Eric Coldwell
Citi Research
Patrick Donnelly
Credit Suisse
Erin Wilson Wright
Deutsche Bank Research
George Hill
Evercore ISI
Elizabeth Anderson
Goldman Sachs
Robert Jones
David Windley
J.P. Morgan
Tycho Peterson
KeyBanc Capital Markets
Donald Hooker
Morgan Stanley
Ricky Goldwasser
Anna Baran
Nephron Research
Jack Meehan
Truist Securities
Sandy Draper
Daniel Brennan
Wells Fargo Securities
Dan Leonard
William Blair
John Kreger
Wolfe Research
Stephen Baxter

Charles River Laboratories International, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Charles River Laboratories International, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Charles River Laboratories International, Inc. or its management. Charles River Laboratories International, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Featured Report

2019 Annual Report (PDF)